Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $4.06 billion. The enterprise value is $3.45 billion.
| Market Cap | 4.06B |
| Enterprise Value | 3.45B |
Important Dates
The next confirmed earnings date is Wednesday, February 11, 2026, before market open.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 244.47 million shares outstanding. The number of shares has increased by 22.84% in one year.
| Current Share Class | 244.47M |
| Shares Outstanding | 244.47M |
| Shares Change (YoY) | +22.84% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 46.59% |
| Float | 120.89M |
Valuation Ratios
The trailing PE ratio is 53.01 and the forward PE ratio is 31.52. Cellebrite DI's PEG ratio is 1.91.
| PE Ratio | 53.01 |
| Forward PE | 31.52 |
| PS Ratio | 8.67 |
| Forward PS | 7.43 |
| PB Ratio | 9.01 |
| P/TBV Ratio | 9.83 |
| P/FCF Ratio | 28.66 |
| P/OCF Ratio | 26.33 |
| PEG Ratio | 1.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 47.83, with an EV/FCF ratio of 24.57.
| EV / Earnings | 45.15 |
| EV / Sales | 7.56 |
| EV / EBITDA | 47.83 |
| EV / EBIT | 56.13 |
| EV / FCF | 24.57 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.11 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 20.46% and return on invested capital (ROIC) is 9.84%.
| Return on Equity (ROE) | 20.46% |
| Return on Assets (ROA) | 5.24% |
| Return on Invested Capital (ROIC) | 9.84% |
| Return on Capital Employed (ROCE) | 11.87% |
| Weighted Average Cost of Capital (WACC) | 11.21% |
| Revenue Per Employee | $390,662 |
| Profits Per Employee | $65,410 |
| Employee Count | 1,167 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 7.96 |
Taxes
In the past 12 months, Cellebrite DI has paid $7.97 million in taxes.
| Income Tax | 7.97M |
| Effective Tax Rate | 9.45% |
Stock Price Statistics
The stock price has decreased by -29.96% in the last 52 weeks. The beta is 1.28, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -29.96% |
| 50-Day Moving Average | 17.85 |
| 200-Day Moving Average | 17.12 |
| Relative Strength Index (RSI) | 40.31 |
| Average Volume (20 Days) | 1,087,444 |
Short Selling Information
The latest short interest is 5.83 million, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 5.83M |
| Short Previous Month | 5.64M |
| Short % of Shares Out | 2.38% |
| Short % of Float | 4.82% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $455.90 million and earned $76.33 million in profits. Earnings per share was $0.31.
| Revenue | 455.90M |
| Gross Profit | 382.80M |
| Operating Income | 61.40M |
| Pretax Income | 84.30M |
| Net Income | 76.33M |
| EBITDA | 72.06M |
| EBIT | 61.40M |
| Earnings Per Share (EPS) | $0.31 |
Balance Sheet
The company has $525.71 million in cash and $21.44 million in debt, with a net cash position of $573.85 million or $2.35 per share.
| Cash & Cash Equivalents | 525.71M |
| Total Debt | 21.44M |
| Net Cash | 573.85M |
| Net Cash Per Share | $2.35 |
| Equity (Book Value) | 447.69M |
| Book Value Per Share | 1.84 |
| Working Capital | 351.49M |
Cash Flow
In the last 12 months, operating cash flow was $152.70 million and capital expenditures -$12.45 million, giving a free cash flow of $140.25 million.
| Operating Cash Flow | 152.70M |
| Capital Expenditures | -12.45M |
| Free Cash Flow | 140.25M |
| FCF Per Share | $0.57 |
Margins
Gross margin is 83.96%, with operating and profit margins of 13.47% and 16.74%.
| Gross Margin | 83.96% |
| Operating Margin | 13.47% |
| Pretax Margin | 18.49% |
| Profit Margin | 16.74% |
| EBITDA Margin | 15.80% |
| EBIT Margin | 13.47% |
| FCF Margin | 30.76% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.84% |
| Shareholder Yield | -22.84% |
| Earnings Yield | 1.90% |
| FCF Yield | 3.49% |
Analyst Forecast
The average price target for Cellebrite DI is $24.40, which is 47.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.40 |
| Price Target Difference | 47.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 17.04% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 7.67 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.67 |
| Piotroski F-Score | 5 |